Literature DB >> 22978633

Modular unfolding and dissociation of the human respiratory syncytial virus phosphoprotein p and its interaction with the m(2-1) antiterminator: a singular tetramer-tetramer interface arrangement.

Sebastián A Esperante1, Gastón Paris, Gonzalo de Prat-Gay.   

Abstract

Paramyxoviruses share the essential RNA polymerase complex components, namely, the polymerase (L), phosphoprotein (P), and nucleoprotein (N). Human respiratory syncytial virus (RSV) P is the smallest polypeptide among the family, sharing a coiled coil tetramerization domain, which disruption renders the virus inactive. We show that unfolding of P displays a first transition with low cooperativity but substantial loss of α-helix content and accessibility to hydrophobic sites, indicative of loose chain packing and fluctuating tertiary structure, typical of molten globules. The lack of unfolding baseline indicates a native state in conformational exchange and metastable at 20 °C. The second transition starts from a true intermediate state, with only the tetramerization domain remaining folded. The tetramerization domain undergoes a two-state dissociation/unfolding reaction (37.3 kcal mol(-1)). The M(2-1) transcription antiterminator, unique to RSV and Metapneumovirus, forms a nonglobular P:M(2-1) complex with a 1:1 stoichiometry and a K(D) of 8.1 nM determined by fluorescence anisotropy, far from the strikingly coincident dissociation range of P and M(2-1) tetramers (10(-28) M(3)). The M(2-1) binding region has been previously mapped to the N-terminal module of P, strongly suggesting the latter as the metastable molten globule domain. Folding, oligomerization, and assembly events between proteins and with RNA are coupled in the RNA polymerase complex. Quantitative assessment of the hierarchy of these interactions and their mechanisms contribute to the general understanding of RNA replication and transcription in Paramyxoviruses. In particular, the unique P-M(2-1) interface present in RSV provides a valuable antiviral target for this worldwide spread human pathogen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22978633     DOI: 10.1021/bi300765c

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Crystal structure of the essential transcription antiterminator M2-1 protein of human respiratory syncytial virus and implications of its phosphorylation.

Authors:  Sian J Tanner; Antonio Ariza; Charles-Adrien Richard; Hannah F Kyle; Rachel L Dods; Marie-Lise Blondot; Weining Wu; José Trincão; Chi H Trinh; Julian A Hiscox; Miles W Carroll; Nigel J Silman; Jean-François Eléouët; Thomas A Edwards; John N Barr
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

2.  Fine mapping and characterization of the L-polymerase-binding domain of the respiratory syncytial virus phosphoprotein.

Authors:  Julien Sourimant; Marie-Anne Rameix-Welti; Anne-Laure Gaillard; Didier Chevret; Marie Galloux; Elyanne Gault; Jean-François Eléouët
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

3.  Drastic changes in conformational dynamics of the antiterminator M2-1 regulate transcription efficiency in Pneumovirinae.

Authors:  Cedric Leyrat; Max Renner; Karl Harlos; Juha T Huiskonen; Jonathan M Grimes
Journal:  Elife       Date:  2014-05-19       Impact factor: 8.140

4.  Quantitative investigation of the affinity of human respiratory syncytial virus phosphoprotein C-terminus binding to nucleocapsid protein.

Authors:  Adam B Shapiro; Ning Gao; Nichole O'Connell; Jun Hu; Jason Thresher; Rong-Fang Gu; Ross Overman; Ian M Hardern; Graham G Sproat
Journal:  Virol J       Date:  2014-11-19       Impact factor: 4.099

5.  Structural dissection of human metapneumovirus phosphoprotein using small angle x-ray scattering.

Authors:  Max Renner; Guido C Paesen; Claire M Grison; Sébastien Granier; Jonathan M Grimes; Cédric Leyrat
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

Review 6.  Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development.

Authors:  Seyhan Boyoglu-Barnum; Tatiana Chirkova; Larry J Anderson
Journal:  Front Immunol       Date:  2019-07-25       Impact factor: 7.561

7.  Two RSV Platforms for G, F, or G+F Proteins VLPs.

Authors:  Binh Ha; Jie E Yang; Xuemin Chen; Samadhan J Jadhao; Elizabeth R Wright; Larry J Anderson
Journal:  Viruses       Date:  2020-08-19       Impact factor: 5.048

Review 8.  Pneumoviral Phosphoprotein, a Multidomain Adaptor-Like Protein of Apparent Low Structural Complexity and High Conformational Versatility.

Authors:  Christophe Cardone; Claire-Marie Caseau; Nelson Pereira; Christina Sizun
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

Review 9.  Interactions between the Nucleoprotein and the Phosphoprotein of Pneumoviruses: Structural Insight for Rational Design of Antivirals.

Authors:  Hortense Decool; Lorène Gonnin; Irina Gutsche; Christina Sizun; Jean-François Eléouët; Marie Galloux
Journal:  Viruses       Date:  2021-12-06       Impact factor: 5.048

10.  RSV hijacks cellular protein phosphatase 1 to regulate M2-1 phosphorylation and viral transcription.

Authors:  Charles-Adrien Richard; Vincent Rincheval; Safa Lassoued; Jenna Fix; Christophe Cardone; Camille Esneau; Sergei Nekhai; Marie Galloux; Marie-Anne Rameix-Welti; Christina Sizun; Jean-François Eléouët
Journal:  PLoS Pathog       Date:  2018-02-28       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.